Why did XAIR surge?

The stock price of XAIR has experienced an increase of 1.84% on July 22, 2025. Beyond Air (XAIR) has recently received several developments that could contribute to the surge in its stock price: 1. **Positive Earnings Report**: Beyond Air reported a 220% increase in revenue for the fiscal year ended March 31, 2025, reaching $3.7 million compared to $1.2 million the previous year. This significant revenue growth indicates a strong business performance, which can boost investor confidence. 2. **Strategic Agreements**: Beyond Air has secured a national group purchasing agreement with Premier, Inc., effective July 15, 2025. This agreement expands market access for the LungFit PH system and disposable NO2 Smart Filters, streamlining sales to major hospital networks. Such partnerships can significantly enhance the commercialization potential of the company's products. 3. **Innovative Technology**: The company's LungFit platform, which utilizes patented Ionizer™ technology to generate nitric oxide, has been highlighted as a groundbreaking advancement. The innovative nature of the technology and its potential to improve patient outcomes can attract investor interest. 4. **Buy Rating and Price Target**: Beyond Air has received a 'Buy' rating from D. Boral Capital, with an analyst setting a price target of $11. This rating and target can instill confidence in investors and potentially attract new buyers. In conclusion, Beyond Air's (XAIR) recent surge in stock price can be attributed to a combination of positive earnings, strategic agreements, innovative technology, and a 'Buy' rating with a higher price target from analysts. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |XAIR|XAIR.O|Beyond Air|20250718|0.6173|186| |XAIR|XAIR.O|Beyond Air|20250721|1.8405|186| |XAIR|XAIR.O|Beyond Air|20250722|1.840490797546014|186|